Selected research
Market Analysis & Forecast
Global Nicotine Gums and Lozenges Market Analysis and Forecast 2026-2032
Market perspective
The global Nicotine Gums and Lozenges market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nicotine Gums and Lozenges is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Nicotine Gums and Lozenges is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Nicotine Gums and Lozenges is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Nicotine Gums and Lozenges is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Nicotine Gums and Lozenges include Novartis, Perrigo Company, Pfizer, Fertin Pharma, Johnson & Johnson, Cipla, Alkalon, GSK and Reynolds American, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Nicotine Gums and Lozenges, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Nicotine Gums and Lozenges, also provides the sales of main regions and countries. Of the upcoming market potential for Nicotine Gums and Lozenges, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nicotine Gums and Lozenges sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nicotine Gums and Lozenges market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nicotine Gums and Lozenges sales, projected growth trends, production technology, application and end-user industry.
Nicotine Gums and Lozenges Segment by Company
Novartis
Perrigo Company
Pfizer
Fertin Pharma
Johnson & Johnson
Cipla
Alkalon
GSK
Reynolds American
Dr. Reddy's Laboratories
Nicotine Gums and Lozenges Segment by Type
2 mg/piece
4 mg/piece
Other
Nicotine Gums and Lozenges Segment by Application
Withdrawal Clinics
Medical Practice
Individual Smokers
Others
Nicotine Gums and Lozenges Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotine Gums and Lozenges market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotine Gums and Lozenges and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotine Gums and Lozenges.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Nicotine Gums and Lozenges in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Nicotine Gums and Lozenges manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nicotine Gums and Lozenges sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2 mg/piece
- 4 mg/piece
- Other
Applications
- Withdrawal Clinics
- Medical Practice
- Individual Smokers
- Others
Companies covered
- Novartis
- Perrigo Company
- Pfizer
- Fertin Pharma
- Johnson & Johnson
- Cipla
- Alkalon
- GSK
- Reynolds American
- Dr. Reddy's Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Nicotine Gums and Lozenges Market by Type
- 1.2.1 Global Nicotine Gums and Lozenges Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 2 mg/piece
- 1.2.3 4 mg/piece
- 1.2.4 Other
- 1.3 Nicotine Gums and Lozenges Market by Application
- 1.3.1 Global Nicotine Gums and Lozenges Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Withdrawal Clinics
- 1.3.3 Medical Practice
- 1.3.4 Individual Smokers
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Nicotine Gums and Lozenges Market Dynamics
- 2.1 Nicotine Gums and Lozenges Industry Trends
- 2.2 Nicotine Gums and Lozenges Industry Drivers
- 2.3 Nicotine Gums and Lozenges Industry Opportunities and Challenges
- 2.4 Nicotine Gums and Lozenges Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Nicotine Gums and Lozenges Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Nicotine Gums and Lozenges Revenue by Region
- 3.2.1 Global Nicotine Gums and Lozenges Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Nicotine Gums and Lozenges Revenue by Region (2021-2026)
- 3.2.3 Global Nicotine Gums and Lozenges Revenue by Region (2027-2032)
- 3.2.4 Global Nicotine Gums and Lozenges Revenue Market Share by Region (2021-2032)
- 3.3 Global Nicotine Gums and Lozenges Sales Estimates and Forecasts 2021-2032
- 3.4 Global Nicotine Gums and Lozenges Sales by Region
- 3.4.1 Global Nicotine Gums and Lozenges Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Nicotine Gums and Lozenges Sales by Region (2021-2026)
- 3.4.3 Global Nicotine Gums and Lozenges Sales by Region (2027-2032)
- 3.4.4 Global Nicotine Gums and Lozenges Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Nicotine Gums and Lozenges Revenue by Manufacturers
- 4.1.1 Global Nicotine Gums and Lozenges Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Nicotine Gums and Lozenges Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Nicotine Gums and Lozenges Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Nicotine Gums and Lozenges Sales by Manufacturers
- 4.2.1 Global Nicotine Gums and Lozenges Sales by Manufacturers (2021-2026)
- 4.2.2 Global Nicotine Gums and Lozenges Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Nicotine Gums and Lozenges Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Nicotine Gums and Lozenges Sales Price by Manufacturers (2021-2026)
- 4.4 Global Nicotine Gums and Lozenges Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Nicotine Gums and Lozenges Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Nicotine Gums and Lozenges Manufacturers, Product Type & Application
- 4.7 Global Nicotine Gums and Lozenges Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Nicotine Gums and Lozenges Market CR5 and HHI
- 4.8.2 2025 Nicotine Gums and Lozenges Tier 1, Tier 2, and Tier 3
5 Nicotine Gums and Lozenges Market by Type
- 5.1 Global Nicotine Gums and Lozenges Revenue by Type
- 5.1.1 Global Nicotine Gums and Lozenges Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Nicotine Gums and Lozenges Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Nicotine Gums and Lozenges Revenue Market Share by Type (2021-2032)
- 5.2 Global Nicotine Gums and Lozenges Sales by Type
- 5.2.1 Global Nicotine Gums and Lozenges Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Nicotine Gums and Lozenges Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Nicotine Gums and Lozenges Sales Market Share by Type (2021-2032)
- 5.3 Global Nicotine Gums and Lozenges Price by Type
6 Nicotine Gums and Lozenges Market by Application
- 6.1 Global Nicotine Gums and Lozenges Revenue by Application
- 6.1.1 Global Nicotine Gums and Lozenges Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Nicotine Gums and Lozenges Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Nicotine Gums and Lozenges Revenue Market Share by Application (2021-2032)
- 6.2 Global Nicotine Gums and Lozenges Sales by Application
- 6.2.1 Global Nicotine Gums and Lozenges Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Nicotine Gums and Lozenges Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Nicotine Gums and Lozenges Sales Market Share by Application (2021-2032)
- 6.3 Global Nicotine Gums and Lozenges Price by Application
7 Company Profiles
- 7.1 Novartis
- 7.1.1 Novartis Company Information
- 7.1.2 Novartis Business Overview
- 7.1.3 Novartis Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Novartis Nicotine Gums and Lozenges Product Portfolio
- 7.1.5 Novartis Recent Developments
- 7.2 Perrigo Company
- 7.2.1 Perrigo Company Company Information
- 7.2.2 Perrigo Company Business Overview
- 7.2.3 Perrigo Company Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Perrigo Company Nicotine Gums and Lozenges Product Portfolio
- 7.2.5 Perrigo Company Recent Developments
- 7.3 Pfizer
- 7.3.1 Pfizer Company Information
- 7.3.2 Pfizer Business Overview
- 7.3.3 Pfizer Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Pfizer Nicotine Gums and Lozenges Product Portfolio
- 7.3.5 Pfizer Recent Developments
- 7.4 Fertin Pharma
- 7.4.1 Fertin Pharma Company Information
- 7.4.2 Fertin Pharma Business Overview
- 7.4.3 Fertin Pharma Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Fertin Pharma Nicotine Gums and Lozenges Product Portfolio
- 7.4.5 Fertin Pharma Recent Developments
- 7.5 Johnson & Johnson
- 7.5.1 Johnson & Johnson Company Information
- 7.5.2 Johnson & Johnson Business Overview
- 7.5.3 Johnson & Johnson Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Johnson & Johnson Nicotine Gums and Lozenges Product Portfolio
- 7.5.5 Johnson & Johnson Recent Developments
- 7.6 Cipla
- 7.6.1 Cipla Company Information
- 7.6.2 Cipla Business Overview
- 7.6.3 Cipla Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Cipla Nicotine Gums and Lozenges Product Portfolio
- 7.6.5 Cipla Recent Developments
- 7.7 Alkalon
- 7.7.1 Alkalon Company Information
- 7.7.2 Alkalon Business Overview
- 7.7.3 Alkalon Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Alkalon Nicotine Gums and Lozenges Product Portfolio
- 7.7.5 Alkalon Recent Developments
- 7.8 GSK
- 7.8.1 GSK Company Information
- 7.8.2 GSK Business Overview
- 7.8.3 GSK Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 GSK Nicotine Gums and Lozenges Product Portfolio
- 7.8.5 GSK Recent Developments
- 7.9 Reynolds American
- 7.9.1 Reynolds American Company Information
- 7.9.2 Reynolds American Business Overview
- 7.9.3 Reynolds American Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Reynolds American Nicotine Gums and Lozenges Product Portfolio
- 7.9.5 Reynolds American Recent Developments
- 7.10 Dr. Reddy's Laboratories
- 7.10.1 Dr. Reddy's Laboratories Company Information
- 7.10.2 Dr. Reddy's Laboratories Business Overview
- 7.10.3 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Product Portfolio
- 7.10.5 Dr. Reddy's Laboratories Recent Developments
8 North America
- 8.1 North America Nicotine Gums and Lozenges Market Size by Type
- 8.1.1 North America Nicotine Gums and Lozenges Revenue by Type (2021-2032)
- 8.1.2 North America Nicotine Gums and Lozenges Sales by Type (2021-2032)
- 8.1.3 North America Nicotine Gums and Lozenges Price by Type (2021-2032)
- 8.2 North America Nicotine Gums and Lozenges Market Size by Application
- 8.2.1 North America Nicotine Gums and Lozenges Revenue by Application (2021-2032)
- 8.2.2 North America Nicotine Gums and Lozenges Sales by Application (2021-2032)
- 8.2.3 North America Nicotine Gums and Lozenges Price by Application (2021-2032)
- 8.3 North America Nicotine Gums and Lozenges Market Size by Country
- 8.3.1 North America Nicotine Gums and Lozenges Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Nicotine Gums and Lozenges Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Nicotine Gums and Lozenges Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Nicotine Gums and Lozenges Market Size by Type
- 9.1.1 Europe Nicotine Gums and Lozenges Revenue by Type (2021-2032)
- 9.1.2 Europe Nicotine Gums and Lozenges Sales by Type (2021-2032)
- 9.1.3 Europe Nicotine Gums and Lozenges Price by Type (2021-2032)
- 9.2 Europe Nicotine Gums and Lozenges Market Size by Application
- 9.2.1 Europe Nicotine Gums and Lozenges Revenue by Application (2021-2032)
- 9.2.2 Europe Nicotine Gums and Lozenges Sales by Application (2021-2032)
- 9.2.3 Europe Nicotine Gums and Lozenges Price by Application (2021-2032)
- 9.3 Europe Nicotine Gums and Lozenges Market Size by Country
- 9.3.1 Europe Nicotine Gums and Lozenges Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Nicotine Gums and Lozenges Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Nicotine Gums and Lozenges Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Nicotine Gums and Lozenges Market Size by Type
- 10.1.1 China Nicotine Gums and Lozenges Revenue by Type (2021-2032)
- 10.1.2 China Nicotine Gums and Lozenges Sales by Type (2021-2032)
- 10.1.3 China Nicotine Gums and Lozenges Price by Type (2021-2032)
- 10.2 China Nicotine Gums and Lozenges Market Size by Application
- 10.2.1 China Nicotine Gums and Lozenges Revenue by Application (2021-2032)
- 10.2.2 China Nicotine Gums and Lozenges Sales by Application (2021-2032)
- 10.2.3 China Nicotine Gums and Lozenges Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Nicotine Gums and Lozenges Market Size by Type
- 11.1.1 Asia Nicotine Gums and Lozenges Revenue by Type (2021-2032)
- 11.1.2 Asia Nicotine Gums and Lozenges Sales by Type (2021-2032)
- 11.1.3 Asia Nicotine Gums and Lozenges Price by Type (2021-2032)
- 11.2 Asia Nicotine Gums and Lozenges Market Size by Application
- 11.2.1 Asia Nicotine Gums and Lozenges Revenue by Application (2021-2032)
- 11.2.2 Asia Nicotine Gums and Lozenges Sales by Application (2021-2032)
- 11.2.3 Asia Nicotine Gums and Lozenges Price by Application (2021-2032)
- 11.3 Asia Nicotine Gums and Lozenges Market Size by Country
- 11.3.1 Asia Nicotine Gums and Lozenges Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Nicotine Gums and Lozenges Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Nicotine Gums and Lozenges Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Nicotine Gums and Lozenges Market Size by Type
- 12.1.1 SAMEA Nicotine Gums and Lozenges Revenue by Type (2021-2032)
- 12.1.2 SAMEA Nicotine Gums and Lozenges Sales by Type (2021-2032)
- 12.1.3 SAMEA Nicotine Gums and Lozenges Price by Type (2021-2032)
- 12.2 SAMEA Nicotine Gums and Lozenges Market Size by Application
- 12.2.1 SAMEA Nicotine Gums and Lozenges Revenue by Application (2021-2032)
- 12.2.2 SAMEA Nicotine Gums and Lozenges Sales by Application (2021-2032)
- 12.2.3 SAMEA Nicotine Gums and Lozenges Price by Application (2021-2032)
- 12.3 SAMEA Nicotine Gums and Lozenges Market Size by Country
- 12.3.1 SAMEA Nicotine Gums and Lozenges Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Nicotine Gums and Lozenges Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Nicotine Gums and Lozenges Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Nicotine Gums and Lozenges Value Chain Analysis
- 13.1.1 Nicotine Gums and Lozenges Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Nicotine Gums and Lozenges Production Mode & Process
- 13.2 Nicotine Gums and Lozenges Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Nicotine Gums and Lozenges Distributors
- 13.2.3 Nicotine Gums and Lozenges Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst